Delivery Order SPE2DB22D2206-SPE2DB26FDS83
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,314.82 to AmerisourceBergen Drug Corp for Fulphila 6 mg/0.6 mL syringes on September 4, 2025, with completion scheduled for September 5, 2025. This delivery order operates under a firm fixed price structure with no set-aside designation, indicating open competitive award. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Fulphila 6 mg/0.6 mL syringes with a ceiling value of $17,539.50 under firm fixed pricing. The order is scheduled for completion by September 15, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $4,787.50 to AmerisourceBergen Drug Corp for the supply of Fulphila 6 mg/0.6 mL syringes on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The product will be delivered to the...
- The Defense Logistics Agency awarded a $30,149.93 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561696863 FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The delivery order, which runs from August 3 to August 4, 2023, was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of the Department of Defense's medical...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $46,117.31 firm fixed price delivery order by the Defense Logistics Agency to supply 4561822342 FULPHILA 6 MG/0.6 ML SYRINGES in quantities of 0.6mL each. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning August 15-16, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues delivery orders...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML. The contract has a ceiling value of $12,452.29 and is a firm fixed-price delivery order type contract with an ultimate completion date of December 27, 2023. The contract is not set aside and was awarded on December 26, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $55,316.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This non-set-aside delivery order was competitively awarded on May 23, 2025, with an ultimate completion date of the same date, indicating this is a discrete fulfillment against AmerisourceBergen's larger contract vehicle. The work will be performed at the contractor's...
- This delivery order, awarded on September 16, 2025, represents a $19,407.98 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp for pharmaceutical and medical supply fulfillment. The non-competitive, non-set-aside award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The work will be performed at the...
- The Defense Logistics Agency Medical Supply Chain awarded a $14,510.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 3, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999,999,999 ceiling and runs through December 2026. The delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $10,976.50 to AmerisourceBergen Drug Corp on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX). The order is to be fulfilled at AmerisourceBergen's corporate office...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDS83Delivery Order
The Defense Logistics Agency awarded a $13,978.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fulphila 6 mg/0.6 mL syringes on October 22, 2025, with completion expected by October 23, 2025. This is a non-set-aside award issued under a competitive process. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order will be fulfilled from the company's Conshohocken facility. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The arrangement reflects DLA's strategy to maintain flexible procurement vehicles with capable vendors to meet the Department of Defense's ongoing pharmaceutical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 10/22/25 |